Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Buderim
Clinical trial register · Australia

Clinical Trials in Buderim, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1099 Adelaide 566 Sydney 511 Westmead 417 Clayton 408
Narrow the registerReset
Recruitment status
Phase
Site location
Melbourne1099 Adelaide566 Sydney511 Westmead417 Clayton408
All 399 locations
Target enrolment
to

Trials with a site in Buderim

17 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
ML-016 in Advanced Cancer With Lung and/or Liver Involvement
NCT07723482Advanced Solid Tumor With Lung and/or Liver Involvement
BrYet US, Inc.
Phase 1/2
108
Miranda, Wollongong, Buderim
2026-09-25
Not yet open
Queensland Centre for Gynaecological Cancer
Phase 3
640
Newcastle, Darwin, Auchenflower, Brisbane, Buderim, Adelaide, Heidelberg, Parkville
2026-06-01
Recruiting
Pfizer
Phase 3
800
Buderim, Woodville South, Hobart, Clayton, Melbourne
2025-12-11
Recruiting
The RECLAIM Study.
NCT06450444Chronic Migraine, High Frequency Episodic Migraine
Salvia BioElectronics
Not applicable
110
Broadmeadow, Buderim
2024-06-24
Recruiting
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
NCT06351631Thrombocythemia, Essential, Primary Myelofibrosis, Myelofibrosis, Post-polycythemia Vera Myelofibrosis
Merck Sharp & Dohme LLC
Phase 3
400
Camperdown, St Leonards, Buderim, Southport, Adelaide, Clayton
2024-05-23
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Frenchs Forest, Kingswood, North Sydney, Buderim, South Brisbane, Adelaide, Geelong, St Albans
2023-12-11
Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
NCT06022029Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Lymphoma, Non-Hodgkin
OncoNano Medicine, Inc.
Phase 1
168
Darlinghurst, Wollongong, Buderim, Southport, Woolloongabba, Bedford Park, Subiaco
2023-10-13
Recruiting
DynamiCure Biotechnology
Phase 1
320
Randwick, Sydney, Buderim, Bedford Park, Woodville South, Clayton, Malvern, Nedlands
2023-06-28
Active, closed
Salvia BioElectronics
Not applicable
5
Buderim
2023-05-02
Active, closed
THIO Sequenced With Cemiplimab in Advanced NSCLC
NCT05208944Carcinoma, Non-Small-Cell Lung
Maia Biotechnology
Phase 2
227
Buderim, Adelaide, Fitzroy
2022-06-08
Recruiting
A Beta-only IL-2 ImmunoTherapY Study
NCT05086692Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma, Triple Negative Breast Cancer
Medicenna Therapeutics, Inc.
Phase 1/2
160
Randwick, Sydney, Buderim, Greenslopes
2021-08-27
Active, closed
HUYABIO International, LLC.
Phase 3
450
Wahroonga, Buderim, South Brisbane, Ballarat, Shepparton, Brisbane, Liverpool, Nedlands
2021-08-12
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
Novartis Pharmaceuticals
Phase 3
430
Brisbane, Adelaide, Clayton, Frankston, Buderim, Nedlands
2021-04-09
Recruiting
Sentinel Node Biopsy in Endometrial Cancer
NCT04073706Endometrial Cancer Stage I, Sentinel Lymph Node, Surgery
Queensland Centre for Gynaecological Cancer
Phase 3
760
Camperdown, Liverpool, Auchenflower, Brisbane, Buderim, Everton Park, Herston, South Brisbane
2021-01-18
Active, closed
Pfizer
Phase 3
896
Liverpool, Birtinya, Bowen Hills, Buderim, Mackay, Maroochydore, North Mackey, Heidelberg
2019-09-05
Active, closed
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
NCT03212404Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell, Malignant Mesothelioma, Advanced
Checkpoint Therapeutics, Inc.
Phase 1
272
Wollongong, Benowa, Buderim, Greenslopes, South Brisbane, Woolloongabba, Box Hill, Malvern
2017-09-20
Rows per page Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/buderim

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 17 of those studies with a site in Buderim.

How many clinical trials are recruiting in Buderim?

9 of the 17 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Buderim), 17 studies
PhaseStudiesRecruitingShare
Phase 39452.9%
Phase 13217.6%
Not applicable2111.8%
Phase 1/22211.8%
Phase 2105.9%

Most active sponsors

Lead sponsors with the most studies (Buderim)
Lead sponsorStudiesRecruiting
Pfizer21
Queensland Centre for Gynaecological Cancer21
Salvia BioElectronics21
Bayer11
BrYet US, Inc.11
Checkpoint Therapeutics, Inc.10
DynamiCure Biotechnology11
Hoffmann-La Roche10
HUYABIO International, LLC.10
Maia Biotechnology10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.